Gould Capital, LLC
- SEC CIK
- 0001908965
- Latest filing
- Aug 7, 2026
IBRX holding history
ImmunityBio, Inc. in every 13F filed by Gould Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IBRX overviewAll 13F holders of IBRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −117−100.0% | Sold out | Holders |
| Q1 2026 | 117 | $897 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 117 | $232 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 117 | $288 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 117 | $309 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 117 | $352 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 117 | $300 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 117 | $435 | <0.1% | +117 | New | Holders |